Piles - Medium Biopsy 1-3 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Histology of hemorrhoidal tissue.

₹370₹529

30% OFF

Piles - Medium Biopsy 1-3 cm

Why is it done?
- To obtain tissue samples from hemorrhoidal lesions measuring 1-3 cm in diameter for histopathological examination
- To exclude malignant or dysplastic changes in suspicious hemorrhoidal tissue
- To differentiate between benign hemorrhoids and other colorectal pathology such as polyps, tumors, or inflammatory lesions
- When hemorrhoidal lesions appear atypical, have unusual presentations, or do not respond to standard conservative treatment
- To evaluate for presence of infection, inflammation, or vascular abnormalities within the biopsy specimen
- Typically performed during anoscopy or colonoscopy when medium-sized hemorrhoids require tissue confirmation
Normal Range
- Normal findings include benign hemorrhoidal tissue characterized by dilated vascular channels, normal squamous epithelium, and absence of malignancy
- No dysplasia present - indicates benign pathology with no premalignant or malignant changes (Negative for malignancy)
- Normal inflammatory response - mild to moderate chronic inflammation consistent with hemorrhoidal disease
- Intact epithelium - surface lining is preserved without significant erosion or ulceration
- Absence of infectious organisms - no evidence of bacterial, viral, or fungal infection on histological examination
- No abnormal vasculature or vascular malformations identified
Interpretation
- Benign Hemorrhoidal Tissue (Normal Finding):
  - Confirms diagnosis of internal or external hemorrhoids Indicates lesion is non-cancerous and management can proceed with standard treatment Reassures patient and clinician regarding absence of malignancy
- Dysplasia Present (Low-Grade or High-Grade):
  - Indicates premalignant changes that require close monitoring or intervention High-grade dysplasia may necessitate surgical excision or ablation Further colonoscopic surveillance may be recommended
- Malignancy (Positive for Cancer):
  - Requires immediate referral to oncology and colorectal surgery Staging studies (CT, MRI, endoscopic ultrasound) will be necessary Treatment planning including surgical resection, chemotherapy, or radiation may be indicated
- Inflammation or Infection:
  - Suggests secondary changes related to hemorrhoidal disease May indicate need for targeted antimicrobial therapy if infection identified Chronic inflammation may warrant more aggressive hemorrhoid management
- Vascular Abnormalities:
  - May indicate vascular malformations or angiodysplasia Could suggest underlying systemic vascular disorder May require additional imaging or interventional management
- Factors Affecting Interpretation:
  - Specimen adequacy - insufficient tissue may limit diagnostic capability Clinical presentation and patient history - correlation with symptoms aids interpretation Previous biopsies or treatments - affects assessment of current pathology Patient age and risk factors - influences malignancy risk assessment
Associated Organs
- Primary Organ System:
  - Distal rectum and anal canal - direct site of hemorrhoid formation Lower gastrointestinal tract - broader anatomical region affected Internal hemorrhoidal venous plexus - specialized vascular network involved External hemorrhoidal venous plexus - subcutaneous venous drainage system
- Conditions Commonly Associated with Abnormal Results:
  - Internal and external hemorrhoids - primary benign finding Colorectal adenocarcinoma - concerning malignant finding Anal canal cancer - less common malignancy in this region Inflammatory bowel disease (Crohn's disease, ulcerative colitis) - underlying inflammatory condition Colorectal polyps - benign growths requiring surveillance Angiodysplasia - vascular malformations prone to bleeding Infectious proctocolitis - sexually transmitted infections or bacterial infections Portal hypertension - leads to ectopic varices in anal region
- Potential Complications or Risks Associated with Abnormal Results:
  - Malignancy diagnosis - requires intensive multimodal therapy with associated side effects Metastatic disease - if cancer present at time of diagnosis, prognosis may be compromised Bleeding complications - if hemorrhoids undergo necrosis or infection Fistula formation - chronic inflammatory changes may lead to anal fistulas Anal stricture - severe inflammation or surgery-related scarring Persistent symptoms - some conditions require multiple interventions Quality of life impact - pain, bleeding, and functional impairment
Follow-up Tests
- If Benign Hemorrhoids Confirmed:
  - Routine colonoscopy in 5-10 years for age-appropriate screening Repeat sigmoidoscopy/anoscopy if symptoms persist or recur Clinical follow-up with colorectal surgeon if conservative management fails No histological follow-up needed if straightforward benign disease
- If Dysplasia Identified:
  - High-grade dysplasia - repeat endoscopy with biopsies in 3 months Surgical consultation for possible hemorrhoidectomy or wide local excision Enhanced surveillance colonoscopy every 1 year for 3-5 years HPV testing if anal dysplasia related to HPV Anoscopy every 3-6 months for low-grade dysplasia
- If Malignancy Detected:
  - Urgent referral to colorectal surgery and medical oncology Computed tomography (CT) of abdomen and pelvis with contrast - staging Endoscopic ultrasound (EUS) - local tumor staging and node assessment Positron emission tomography (PET-CT) - assessment for metastatic disease Carcinoembryonic antigen (CEA) level - baseline tumor marker Chest imaging - exclude pulmonary metastases Liver function tests and complete metabolic panel Multidisciplinary tumor board review for treatment planning
- If Infection Identified:
  - Bacterial culture and sensitivity if appropriate STI testing panel if sexually transmitted infection suspected Targeted antimicrobial therapy based on organism identification Follow-up endoscopy after treatment completion Serologic testing if viral infection suspected (HSV, HPV)
- Related Complementary Tests:
  - Complete colonoscopy - visualize entire colon if not yet performed Flexible sigmoidoscopy - if full colonoscopy not tolerated Transanal ultrasound - assess anal sphincter and deep tissue layers Manometry - evaluate sphincter function if incontinence present Proctography - assess for structural abnormalities
Fasting Required?
- Fasting Required: YES
  - Fasting Duration: 6-8 hours before procedure (standard NPO status) If procedure scheduled for morning, fast from midnight If procedure scheduled for afternoon, light breakfast may be permitted early morning (consult facility)
- Fluid Intake: Clear fluids typically allowed up to 2 hours before procedure Water, clear broths, apple juice, white grape juice permitted Avoid milk, cream, or opaque beverages
- Medications:
  - Anticoagulants (warfarin, apixaban, rivaroxaban) - notify provider; may need temporary discontinuation or bridging Antiplatelet agents (aspirin, clopidogrel) - typically continue unless high bleeding risk NSAIDs - may increase bleeding risk; discuss with provider Iron supplements - discontinue 3-5 days before if possible Diabetes medications - take with small sip of water on morning of procedure Continue essential cardiac and antihypertensive medications as directed
- Bowel Preparation:
  - For anoscopy - mild bowel prep or enema may be recommended For colonoscopy - complete bowel preparation (polyethylene glycol solution or other laxative preparation) Preparation typically begins 1 day before procedure Follow facility-specific preparation instructions provided at time of scheduling
- Additional Patient Preparation:
  - Arrange for someone to provide transportation home (procedure requires sedation/anesthesia) Avoid driving or operating machinery for 24 hours after procedure Remove all metallic jewelry and clothing from lower body Empty bladder before procedure Wear comfortable, easy-to-remove clothing Allergy history documentation - especially latex allergy Informed consent discussion regarding procedure risks and biopsy

How our test process works!